Mr. David Giddings —
After playing several VP-level roles at Eastman Kodak, Mr. Giddings joined Boehringer Mannheim Corporation in 1991 as VP and General Manager of their Diagnostics Division, subsequently becoming President and COO of the company. He was appointed Chairman, President, and CEO of Diametrics Medical in 1995, a NASDAQ traded company, where he served for 6 years. Mr. Giddings joined Digilab LLC as its President in 2001.
Mr. Giddings has served on a number of boards including ACCPAC, formerly a wholly owned subsidiary of Computer associates; Gentra Systems Inc., sold to Qiagen with Mr. Giddings managing a board initiative to facilitate this M&A transaction; and Heartsine Inc., a global leader in AED and Atrial Fibrilation Technology/Products located in Belfast. Currently, Mr. Giddings serves on the board of Liposcience Inc, a market leader in advanced cardiovascular testing services and products and Axela Biosciences, a market leader in instrumentation and consumables to support multiplexed protein assay development for clinical use.
Michal Lipson —
Dr. Lipson is an Associate Professor of Electrical and Computer Engineering at Cornell University. Her research focuses on novel on-chip nanophotonics devices. She holds numerous patents on novel micron-size photonic structures for light manipulation, and is the author of over 100 papers in journals in physics and optics. She has pioneered several of the critical building blocks for silicon photonics including the GHz silicon modulators.
Dr. Lipson was named as a MacArthur Genius Fellow in 2010. She is also a Fellow of the Optical Society of America and recipient of an NSF Career Award.
Professor Brian C Wilson —
Dr Wilson is a pioneer in the field of laser biophysics and the head of the division of Biophysics and Imaging at the Ontario Cancer Institute. His research focuses on the development and application of new therapeutic and diagnostic techniques based on the use of lasers and other optical technologies.
In this translational research, a wide range of methodologies are used: theoretical and experimental studies of light transport in tissues, development of light sources/optical-fiber light delivery devices and of optical dosimeters, photobiological studies at the cellular and tissue level, in vivo optical spectroscopy of tissues, development of prototype clinical instruments, and co-operative clinical trials.
Dr. Ted James —
Dr. James is a Practicing Surgical Oncologist and a Breast Cancer Specialist at the University of Vermont College of Medicine. He is board certified in surgery and treats patients with breast cancer and melanoma. Dr. James has expertise in the multidisciplinary management of breast disease, oncoplastic surgery, sentinel node biopsy and minimally invasive breast cancer surgery. He provides leadership to oncology and medical education organizations both locally and nationally.
Dr. James has served as a Cancer Committee Chair, liaison to the national Commission on Cancer and board member of the American Cancer Society.
Sid Braginsky — New York, New York
From 1970 until 2000, Mr. Braginsky served as President of Olympus Corp. Mr. Braginsky has served as the Chairman and Chief Executive Officer of Digilab Corp. (a spectroscopy instruments manufacturer) since 2005, and as Chairman of Activeases Corp. (a therapeutic device manufacturer) since 2007. Mr. Braginsky is currently a director and member of the audit committee of DJO, Inc. (a Blackstone Group company) and served as a director of Noven Pharmaceuticals, Inc. until 2009.
He is also Chairman of the International Standards Organization U.S. Technical Advisory Group TC 172 on Optics and Photonics, Chairman of the Board of the City University of New York Robert Chambers Laboratory and Trustee on the boards of the Long Island High Tech Incubator and the Long Island Museum of Science and Technology. Mr. Braginsky received his B.S. in biology from Queens College.